123 related articles for article (PubMed ID: 17610180)
1. Gastric outlet obstruction due to an iatrogenic cause in a neonatal period - report of two cases.
Kosiak W; Swieton D; Fryze I; Aleszewicz-Baranowska J; Duklas M; Chojnicki M
Ultraschall Med; 2009 Aug; 30(4):401-3. PubMed ID: 17610180
[TBL] [Abstract][Full Text] [Related]
2. Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis.
Lacher M; Schneider K; Dalla Pozza R; Schweinitz DV
Eur J Pediatr Surg; 2007 Oct; 17(5):362-4. PubMed ID: 17968795
[TBL] [Abstract][Full Text] [Related]
3. Acute gastric outlet obstruction following the administration of prostaglandin: an additional case.
Kobayashi N; Aida N; Nishimura G; Kashimura T; Ohta M; Kawataki M
Pediatr Radiol; 1997 Jan; 27(1):57-9. PubMed ID: 8995170
[TBL] [Abstract][Full Text] [Related]
4. Gastric-outlet obstruction induced by prostaglandin therapy in neonates.
Peled N; Dagan O; Babyn P; Silver MM; Barker G; Hellmann J; Scolnik D; Koren G
N Engl J Med; 1992 Aug; 327(8):505-10. PubMed ID: 1635565
[TBL] [Abstract][Full Text] [Related]
5. Pseudo-Bartter syndrome in a neonate on prostaglandin infusion.
Vanhaesebrouck S; Allegaert K; Vanhole C; Devlieger H; Gewillig M; Proesmans W
Eur J Pediatr; 2003 Sep; 162(9):569-71. PubMed ID: 12811550
[TBL] [Abstract][Full Text] [Related]
6. Radiologic features of gastric outlet obstruction in infants after long-term prostaglandin administration.
Babyn P; Peled N; Manson D; Dagan O; Silver MM; Koren G
Pediatr Radiol; 1995; 25(1):41-3; discussion 44. PubMed ID: 7761161
[TBL] [Abstract][Full Text] [Related]
7. Gastric thumbprinting: diffuse gastric wall mucosal and submucosal thickening in infants with ductal-dependent cyanotic congenital heart disease maintained on long-term prostaglandin therapy.
Joshi A; Berdon WE; Brudnicki A; LeQuesne G; Ruzal-Shapiro C; Hayes C
Pediatr Radiol; 2002 Jun; 32(6):405-8. PubMed ID: 12029339
[TBL] [Abstract][Full Text] [Related]
8. Complications of Long-Term Prostaglandin E1 Use in Newborns With Ductal-Dependent Critical Congenital Heart Disease.
Alhussin W; Verklan MT
J Perinat Neonatal Nurs; 2016; 30(1):73-9. PubMed ID: 26813395
[TBL] [Abstract][Full Text] [Related]
9. Case report 701: Prostaglandin E1 (PGE1) periostitis.
Rowley RF; Lawson JP
Skeletal Radiol; 1991; 20(8):617-9. PubMed ID: 1776031
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
[TBL] [Abstract][Full Text] [Related]
11. Prolonged prostaglandin E1 therapy in a neonate with pulmonary atresia and ventricular septal defect and the development of antral foveolar hyperplasia and hypertrophic pyloric stenosis.
Perme T; Mali S; Vidmar I; Gvardijančič D; Blumauer R; Mishaly D; Grabnar I; Nemec G; Grosek S
Ups J Med Sci; 2013 May; 118(2):138-42. PubMed ID: 23521358
[TBL] [Abstract][Full Text] [Related]
12. Transient hypertrophic pyloric stenosis due to prostoglandin infusion.
Soyer T; Yalcin S; Bozkaya D; Yiğit S; Tanyel FC
J Perinatol; 2014 Oct; 34(10):800-1. PubMed ID: 25263728
[TBL] [Abstract][Full Text] [Related]
13. Neonatal transport issues with prostaglandin E1 infusions.
Grubbs TC; Kraft NL
Air Med J; 2002; 21(3):8-12. PubMed ID: 11994726
[No Abstract] [Full Text] [Related]
14. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.
Reddy SC; Saxena A
Indian J Pediatr; 1998; 65(2):211-6. PubMed ID: 10771966
[TBL] [Abstract][Full Text] [Related]
15. Oral prostaglandin E1 derivative (OP-1206) in an infant with double outlet right ventricle and pulmonary stenosis. Effect on ductus-dependent pulmonary circulation.
Saji T; Matsuura H; Hoshino K; Yamamoto S; Ishikita T; Matsuo N
Jpn Heart J; 1991 Sep; 32(5):735-40. PubMed ID: 1774835
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin-induced hyperostosis. A case report.
Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
[TBL] [Abstract][Full Text] [Related]
17. The development of hypertrophic pyloric stenosis in a patient with prostaglandin-induced foveolar hyperplasia.
Callahan MJ; McCauley RG; Patel H; Hijazi ZM
Pediatr Radiol; 1999 Oct; 29(10):748-51. PubMed ID: 10525782
[TBL] [Abstract][Full Text] [Related]
18. Effect of prostaglandin-E1 treatment on pyloric wall thickness in newborns with ductal-dependent critical congenital heart diseases.
Tandircioglu UA; Turer OB; Soyer T; Ayaz E; Ozcan HN; Yigit S; Celik HT
Pediatr Surg Int; 2023 Mar; 39(1):144. PubMed ID: 36856877
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E1 and gastric outlet obstruction in infants.
Merkus PJ; Cromme-Dijkhuis AH; Robben SG; Hess J
Lancet; 1993 Sep; 342(8873):747. PubMed ID: 8103857
[No Abstract] [Full Text] [Related]
20. Idiopathic focal foveolar hyperplasia in infants.
Holland AJ; Freeman JK; Le Quesne GW; Khong TY
Pediatr Surg Int; 1997 Sep; 12(7):497-500. PubMed ID: 9238115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
